Correlation of Serum Triglyceride Levels with the Severity of Acute Pancreatitis: A Retrospective Study

Read full text Summarise with VIRAT
Authors: Chirag M. Gowda, Sameechi M., Manjunath Irappa Pattanshetti
Cited by: 0
References: 10

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Acute pancreatitis (AP) is a potentially lethal illness with a grim prognosis if it progresses to its severe form. The pathogenesis of acute pancreatitis is linked to serum triglyceride levels. The correlation between blood triglyceride (TG) levels and the severity of acute pancreatitis (AP) is inadequately comprehended. This study aims to examine the relationship between serum triglyceride levels and the severity of acute pancreatitis. Aim: To assess the impact of triglyceride levels on the severity of hypertriglyceridemic pancreatitis (HTGP). Methods: Patients were prospectively enrolled using APPRENTICE. Elevated triglyceride levels were established according to the Endocrine Society Clinical Practice Guidelines. HTG was classified as mild (serum TG levels 150 mg/dL), moderate (150–499 mg/dL), severe (500–999 mg/dL), and very severe (≥1,000 mg/dL). The severity of acute pancreatitis was determined according to the updated Atlanta categorization criteria. Results: 46 % of patients exhibited high blood triglyceride levels (>150 mg/dL). The Revised Atlanta Classification indicates that 46 patients experienced mild acute pancreatitis, 32 had moderately severe acute pancreatitis, and 16 suffered from severe acute pancreatitis. Severe acute pancreatitis was more commonly observed in patients with triglyceride levels ≥500 mg/dL. Conclusions: The present investigation identified elevated blood triglyceride levels as an independent predictor of increased severity of acute pancreatitis and unfavorable clinical outcomes in patients with elevated serum triglycerides. This study endorses serum TG levels as a dependable metric for the swift identification of high-risk AP patients, enabling timely interventions and enhanced results.

Fields of Study & Subjects

Pancreatitis Pathology and Treatment Gallbladder and Bile Duct Disorders Pancreatic and Hepatic Oncology Research

Publication details

Journal / source
International Journal of Current Pharmaceutical Review and Research
Volume
18
Issue
01
Publication date
30 January 2026
Language
EN